Related Experiment Video
Updated: Jun 3, 2026
Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine
Published on: February 24, 2023
Ex vivo cytokine gene transfer in melanomas by using particle bombardment
1Clinical Cooperation Unit for Dermatology at the Department of Dermatology Clinics, Mannheim Universität Heidelberg, Mannheim, Germany.
Abstract:
Melanoma is a malignant tumor of neuroectodermal origin with an increasing incidence and mortality. It needs to be detected and eliminated early, because melanoma is characterized by its high resistance to the conventional therapies, including surgery and chemotherapy (1-3). On the other hand, melanoma is supposed to be one of the most immunogenic tumors which is demonstrated by tumor-infiltrating lymphocytes (TIL) destroying melanoma cells (4-6). This may also be responsible for the occurrence of spontaneous partial or complete melanoma regression and for concomitant destruction of melanocytes in benign lesions, leading to clinical phenomena such as halo nevi, uveitis, and vitiligo in melanoma patients.
Insights
Melanoma, a dangerous skin cancer, is hard to treat but highly immunogenic. Its immune response can cause spontaneous tumor regression and affect melanocytes, leading to conditions like vitiligo.
Area of Science:
- Oncology
- Immunology
- Dermatology
Background:
- Melanoma incidence and mortality are rising globally.
- It exhibits resistance to conventional treatments like surgery and chemotherapy.
- Melanoma is recognized as a highly immunogenic tumor type.
Purpose of the Study:
- To explore the immunogenic nature of melanoma.
- To understand the role of tumor-infiltrating lymphocytes (TILs) in melanoma.
- To investigate the link between melanoma's immunogenicity and spontaneous regression or associated phenomena.
Main Methods:
- Review of existing literature on melanoma immunology and treatment resistance.
- Analysis of studies detailing tumor-infiltrating lymphocytes (TILs) in melanoma.
- Examination of clinical observations of spontaneous melanoma regression and associated autoimmune phenomena.
Main Results:
- Melanoma's resistance to therapy is contrasted by its significant immunogenicity.
- Tumor-infiltrating lymphocytes (TILs) actively participate in destroying melanoma cells.
- Immune responses in melanoma patients can lead to spontaneous tumor regression and affect melanocytes in benign lesions.
Conclusions:
- Melanoma's immunogenicity is a critical factor in its clinical behavior.
- The immune system's role in melanoma offers potential therapeutic avenues.
- Understanding melanoma-induced immune responses may explain associated conditions like vitiligo and halo nevi.
